CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report)’s share price dropped 3.2% on Thursday . The stock traded as low as $1.40 and last traded at $1.41. Approximately 73,320 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 982,370 shares. The stock had previously closed at $1.46.
CERo Therapeutics Stock Down 2.8 %
The company’s fifty day moving average price is $2.37.
CERo Therapeutics Company Profile
CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
See Also
- Five stocks we like better than CERo Therapeutics
- 3 Stocks to Consider Buying in October
- MarketBeat Week in Review – 4/22 – 4/26
- Which Wall Street Analysts are the Most Accurate?
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is Forex and How Does it Work?
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
